DRAVP ID Peptide Name Source Target Organism Patent No
DRAVPa2361 Sequence 18 from CN118852366A SARS-CoV-2 SARS-CoV-2 CN118852366A
DRAVPa2362 Sequence 29 from CN118852366A SARS-CoV-2 SARS-CoV-2 CN118852366A
DRAVPa2363 Sequence 32 from CN118852366A SARS-CoV-2 SARS-CoV-2 CN118852366A
DRAVPa2364 Sequence 1 from CN118725023A Synthetic construct COVID-19 CN118725023A
DRAVPa2365 Sequence 2 from CN118725023A Synthetic construct COVID-19 CN118725023A
DRAVPa2366 Sequence 3 from CN118725023A Synthetic construct COVID-19 CN118725023A
DRAVPa2367 Sequence 4 from CN118725023A Synthetic construct COVID-19 CN118725023A
DRAVPa2368 Sequence 2 from Patent CN118615425A Synthetic construct IAV CN118615425A
DRAVPa2369 Sequence 3 from Patent CN118615425A Synthetic construct IAV CN118615425A
DRAVPa2370 Sequence 4 from Patent CN118615425A Synthetic construct IAV CN118615425A
DRAVPa2371 Sequence 5 from Patent CN118615425A Synthetic construct IAV CN118615425A
DRAVPa2372 Sequence 1 from Patent CN118530344A Synthetic construct AAV CN118530344A
DRAVPa2373 Sequence 1 from Patent CN118530345A Synthetic construct AAV CN118530345A
DRAVPa2374 Sequence 2 from Patent CN118530345A Synthetic construct AAV CN118530345A
DRAVPa2375 Sequence 1 from Patent CN119613505A Synthetic construct HBV CN119613505A
DRAVPa2376 Sequence 2 from Patent CN119613505A Synthetic construct HBV CN119613505A
DRAVPa2377 Sequence 3 from Patent CN119613505A Synthetic construct HBV CN119613505A
DRAVPa2378 Sequence 4 from Patent CN119613505A Synthetic construct HBV CN119613505A
DRAVPa2379 Sequence 1 from Patent CN119630683A Synthetic construct SARS-CoV-2 CN119630683A
DRAVPa2380 Sequence 2 from Patent CN119630683A Synthetic construct SARS-CoV-2 CN119630683A
First 116 117 118 119 120 121 122 Last